ICRF has awarded more than $78 million in funding to support over 2,500 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s)InstitutionGrant TypeResearch TopicsGrant Status
Neta Erez, PhD Tel Aviv University Project Grant Animal Modes of Cancer, Breast Cancer, Cancer Metastasis, Clinical and Translational Research, Immunology and Immunotherapy, Lung Cancer, Model Organisms Active
Tal Falick Michaeli, MD Hebrew University of Jerusalem Postdoctoral Fellowship Animal Modes of Cancer, Cancer Metastasis, Colorectal Cancer, Epigenetics, Genetics and Genomics, Molecular Biology Active
Lucio Frydman, PhD Weizmann Institute of Science Acceleration Grant Cancer Metabolism, Deuterium Magnetic Resonance, Early Detection, MRI Active
Yaron Fuchs, PhD Technion, Israel Institute of Technology Acceleration Grant Skin Cancer Non-active
Noa Furth, PhD Weizmann Institute of Science Postdoctoral Fellowship Blood Cancers, Brain Cancer, Cell Signaling, Chromatin, Epigenetics, Genetics and Genomics, Pediatric Cancer, Proteomics and Protein Structures Non-active
Naama Geva-Zatorsky, PhD Technion, Israel Institute of Technology Acceleration Grant Colorectal Cancer, Gastrointestinal Cancer, Inflammation and Cancer Non-active
Ziv Gil, MD, PhD Rambam Health Care Campus ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Chemotherapy, Pancreatic Cancer Non-active
Hava Gil-Henn, PhD Bar-Ilan University Project Grant Animal Modes of Cancer, Cancer Metastasis, Cell Signaling, Proteomics and Protein Structures, Women’s Cancers Active
Moshe Giladi, MD, PhD Tel Aviv University Research Career Development Award Cancer Metastasis, Gastrointestinal Cancer, Lung Cancer, Metabolism and Cancer, Oncogenesis, Proteomics and Protein Structures Active
Yafit Gilboa, PhD Hebrew University of Jerusalem Brause Family Initiative for Quality of Life Grant Cancer-Related Cognitive Decline, Clinical and Translational Research, Quality of Life Active